BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23665160)

  • 21. The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease.
    Aflaki E; Westbroek W; Sidransky E
    Neuron; 2017 Feb; 93(4):737-746. PubMed ID: 28231462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gaucher disease.
    Beutler E
    Adv Genet; 1995; 32():17-49. PubMed ID: 7741022
    [No Abstract]   [Full Text] [Related]  

  • 23. Alleles with more than one mutation can complicate genotype/phenotype studies in Mendelian disorders: Lessons from Gaucher disease.
    Hassan S; Lopez G; Stubblefield BK; Tayebi N; Sidransky E
    Mol Genet Metab; 2018 Sep; 125(1-2):1-3. PubMed ID: 29980418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gaucher disease.
    Butters TD
    Curr Opin Chem Biol; 2007 Aug; 11(4):412-8. PubMed ID: 17644022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RecTL: a complex allele of the glucocerebrosidase gene associated with a mild clinical course of Gaucher disease.
    Zimran A; Horowitz M
    Am J Med Genet; 1994 Mar; 50(1):74-8. PubMed ID: 8160756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital ichthyosis in severe type II Gaucher disease with a homozygous null mutation.
    Haverkaemper S; Marquardt T; Hausser I; Timme K; Kuehn T; Hertzberg C; Rossi R
    Neonatology; 2011; 100(2):194-7. PubMed ID: 21455010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 2 Gaucher disease: phenotypic variation and genotypic heterogeneity.
    Gupta N; Oppenheim IM; Kauvar EF; Tayebi N; Sidransky E
    Blood Cells Mol Dis; 2011 Jan; 46(1):75-84. PubMed ID: 20880730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism.
    DePaolo J; Goker-Alpan O; Samaddar T; Lopez G; Sidransky E
    Mov Disord; 2009 Aug; 24(11):1571-8. PubMed ID: 19425057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gaucher or pseudo-Gaucher? The challenge of several diseases colliding in a pediatric patient.
    Cajaiba MM; Reyes-Múgica M
    Hum Pathol; 2009 Apr; 40(4):594-8. PubMed ID: 19084264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease.
    McEachern KA; Nietupski JB; Chuang WL; Armentano D; Johnson J; Hutto E; Grabowski GA; Cheng SH; Marshall J
    J Gene Med; 2006 Jun; 8(6):719-29. PubMed ID: 16528760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gaucher disease: complexity in a "simple" disorder.
    Sidransky E
    Mol Genet Metab; 2004; 83(1-2):6-15. PubMed ID: 15464415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induced pluripotent stem cell line (INSAi001-A) from a Gaucher disease type 3 patient compound heterozygote for mutations in the GBA1 gene.
    Duarte AJ; Ribeiro D; Santos R; Moreira L; Bragança J; Amaral O
    Stem Cell Res; 2019 Dec; 41():101595. PubMed ID: 31678773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gaucher disease: in vivo evidence for allele dose leading to neuronopathic and nonneuronopathic phenotypes.
    Zhao H; Bailey LA; Elsas LJ; Grinzaid KA; Grabowski GA
    Am J Med Genet A; 2003 Jan; 116A(1):52-6. PubMed ID: 12476451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocerebrosidase mutations are not found in association with LRRK2 G2019S in subjects with parkinsonism.
    Eblan MJ; Scholz S; Stubblefield B; Gutti U; Goker-Alpan O; Hruska KS; Singleton AB; Sidransky E
    Neurosci Lett; 2006 Aug; 404(1-2):163-5. PubMed ID: 16781064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular fibrosis, hydrocephalus, ophthalmoplegia, and visceral involvement in an American child with Gaucher disease.
    Stone DL; Tayebi N; Coble C; Ginns EI; Sidransky E
    J Med Genet; 2000 Nov; 37(11):E40. PubMed ID: 11073549
    [No Abstract]   [Full Text] [Related]  

  • 36. Retinal nerve fiber layer thickness measurements in rats with spectral domain-optical coherence tomography.
    Huang J; Savini G; Feng Y; Wang Q
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):749-50. PubMed ID: 22331506
    [No Abstract]   [Full Text] [Related]  

  • 37. Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses.
    Cox TM
    J Inherit Metab Dis; 2001; 24 Suppl 2():106-21; discussion 87-8. PubMed ID: 11758671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gaucher disease plus.
    Sidransky E; Ginns EI
    J Med Genet; 1997 Oct; 34(10):876-7. PubMed ID: 9350830
    [No Abstract]   [Full Text] [Related]  

  • 39. Glucocerebrosidase mutations in subjects with parkinsonism.
    Lwin A; Orvisky E; Goker-Alpan O; LaMarca ME; Sidransky E
    Mol Genet Metab; 2004 Jan; 81(1):70-3. PubMed ID: 14728994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type I Gaucher's disease with homozygous R463C mutation without neurological involvement.
    Bolaman Z; Kadikoylu G; Levi E; Barutca S; Temucin K
    Haematologia (Budap); 2002; 32(4):487-93. PubMed ID: 12803123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.